Bristol Medical School

Baby teeth may one day help identify kids at risk for mental disorders later in life

Like the rings of a tree, teeth contain growth lines that may reveal clues about childhood experiences. The thickness of growth marks in primary (or “baby”) teeth may help identify children at risk for depression and other mental health disorders later in life, according to a ground-breaking investigation led by researchers at Massachusetts General Hospital (MGH) using data from a world-renowned health study in Bristol and published in JAMA Network Open.

Guidelines may promote over-diagnosis of cow’s milk allergy in infants

International guidelines developed to help doctors diagnose cow’s milk allergy may lead to over-diagnosis, according to University of Bristol-led research published in the journal Clinical and Experimental Allergy today [8 December]. The study found that three-quarters of infants have two or more symptoms at some point in the first year of life, which guidelines say may be caused by cow’s milk allergy, yet the condition only affects one in 100.

Five ways to strike a happy, healthy, and safe balance as England team shoots for Euro 2020 glory amidst COVID-19 pandemic

The countdown for England’s big game has begun and all hopes are set on victory at the Euro 2020 Final. If you’re looking for advice to make the most of the experience, win or lose, while also striking a balance and being kind to others, experts at the University of Bristol are on the ball with top tips to help you through the inevitable ups and downs on Sunday.

Collaborative COVID-19 lockdown effort delivers major boost for vaccine innovation in Bristol

Faster vaccine development could be a step closer thanks to £4 million investment to Imophoron Ltd, a Bristol University biotech start-up developing a novel, next generation rapid-response vaccine platform called ADDomer™. Imophoron will use the investment to bring ADDomer vaccines to clinical stage, initially targeting three viruses, RSV (respiratory syncytial virus), COVID-19, and mosquito-borne Chikungunya.